source
- Geopolitics ‘chills’ British biotech IPO plans, despite $2B in Q2 VC fundsGeopolitical uncertainty has continued to “chill” IPO sentiment among British biotechs, an industry leader has told Fierce, even as the sector saw second-quarter venture capital funding reach a fiv…Fierce Biotech · 12d ago↗ source
- Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businessesAbbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.Fierce Biotech · 12d ago↗ source
- Opinion: Beware the unintended consequences of testosterone screening for military servicemembers“I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended consequences,” writes a urologist who studies testosterone.